Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine

<div>Histograms represent the mean (± SE) duration of the cortical silent period (CSP) from the FDI (a) and ADM (b) muscles at basal conditions and following two progressively fatiguing tasks (Post-1 and Post-2) recorded in MS patients before and after the amantadine treatment. Statistics of the repeated measures ANOVA are reported in the text.</div>

Neural Plasticity

fig3

Figure 3

Figure 3: Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 

Figure 3 | Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 